Imaging Agent Can Change Plans for Recurrent Prostate Cancer Imaging Agent Can Change Plans for Recurrent Prostate Cancer

Clinicians viewing scans using the imaging agent 18F-fluciclovine changed their management plans in 61% of cases of biochemical recurrence of prostate cancer.Medscape Medical News

Source: Medscape Medical News Headlines - February 13, 2018 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news